At the time of writing, Leap Therapeutics Inc [LPTX] stock is trading at $3.07, up 10.04%. An important factor to consider is whether the stock is rising or falling in short-term value. The LPTX shares have gain 15.85% over the last week, with a monthly amount drifted -16.35%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Leap Therapeutics Inc [NASDAQ: LPTX] stock has seen the most recent analyst activity on June 28, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $8. Previously, Mizuho started tracking the stock with Buy rating on October 04, 2021, and set its price target to $6. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $6 on June 29, 2020. Robert W. Baird initiated its recommendation with a Outperform and recommended $6 as its price target on February 11, 2020. Raymond James downgraded its rating to Mkt Perform for this stock on November 15, 2019.
For the past year, the stock price of Leap Therapeutics Inc fluctuated between $1.68 and $5.00. Currently, Wall Street analysts expect the stock to reach $5.5 within the next 12 months. Leap Therapeutics Inc [NASDAQ: LPTX] shares were valued at $3.07 at the most recent close of the market. An investor can expect a potential return of 79.15% based on the average LPTX price forecast.
Analyzing the LPTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -108.44%, Pretax Profit Margin comes in at -100.76%, and Net Profit Margin reading is -101.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is -1.16 and Total Capital is -1.4.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.82 points at the first support level, and at 2.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.35, and for the 2nd resistance point, it is at 3.62.
Ratios To Look Out For
It is important to note that Leap Therapeutics Inc [NASDAQ:LPTX] has a current ratio of 3.97. On the other hand, the Quick Ratio is 3.97, and the Cash Ratio is 3.9.